Literature DB >> 2307988

Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood.

C A Felix1, D G Poplack, G H Reaman, S M Steinberg, D E Cole, B J Taylor, C G Begley, I R Kirsch.   

Abstract

Immunoglobulin (Ig) and T-cell receptor (TCR) genes were examined in the lymphoblasts of 70 children with immunophenotypically defined B-cell precursor acute lymphoblastic leukemia (ALL). The most frequent genes to rearrange were Ig heavy (H) chain (93%) and TCR delta (79%), followed by TCR gamma (49%), Ig kappa and/or lambda light (L) chain (46%), TCR alpha (46%), and TCR beta (29%). Thus, despite their putative "B-cell precursor" lineage, these leukemias manifest a remarkably high incidence of TCR gene rearrangements. While certain patterns predominate, there is considerable heterogeneity in Ig and TCR genotypes in this disease. No significant associations were found between Ig and TCR genotype and commonly used prognostic factors including age, sex, race, WBC, French-American-British (FAB) subtype, or cytogenetics. However, the lymphoblasts of three of six patients who failed to achieve initial remission had germline patterns of every Ig and TCR gene, a genotype not observed in the leukemic cells from any of the 64 patients who achieved complete remission (p2 = .0007). This study suggests that particular Ig and TCR genotypes may be of clinical relevance in childhood B-cell precursor ALL. The finding of rearranged TCR genes in a large proportion of cases raises fundamental questions about early lineage commitment and lymphocyte differentiation along B-cell and T-cell pathways.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307988     DOI: 10.1200/JCO.1990.8.3.431

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  9 in total

1.  Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias.

Authors:  M D Megonigal; E F Rappaport; D H Jones; C S Kim; P C Nowell; B J Lange; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.

Authors:  M D Megonigal; N K Cheung; E F Rappaport; P C Nowell; R B Wilson; D H Jones; K Addya; D G Leonard; B H Kushner; T M Williams; B J Lange; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.

Authors:  C A Felix; D D'Amico; T Mitsudomi; M M Nau; F P Li; J F Fraumeni; D E Cole; J McCalla; G H Reaman; J Whang-Peng
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.

Authors:  C A Felix; M M Nau; T Takahashi; T Mitsudomi; I Chiba; D G Poplack; G H Reaman; D E Cole; J J Letterio; J Whang-Peng
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

5.  t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes.

Authors:  M D Megonigal; E F Rappaport; D H Jones; T M Williams; B D Lovett; K M Kelly; P H Lerou; T Moulton; M L Budarf; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

6.  Presence of more than two rearranged immunoglobulin heavy-chain genes in adult precursor B-cell acute lymphoblastic leukemia.

Authors:  C Schardt; D Hoelzer; A Ganser
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

7.  Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.

Authors:  Brent Wood; David Wu; Beryl Crossley; Yunfeng Dai; David Williamson; Charles Gawad; Michael J Borowitz; Meenakshi Devidas; Kelly W Maloney; Eric Larsen; Naomi Winick; Elizabeth Raetz; William L Carroll; Stephen P Hunger; Mignon L Loh; Harlan Robins; Ilan Kirsch
Journal:  Blood       Date:  2017-12-28       Impact factor: 22.113

8.  Isolated primary testicular B lymphoblastic lymphoma: an unusual presentation.

Authors:  Alejandro V Garcia; Bachir Alobeid; Jocelyn M Traina; Susie S Chen; Michael A Weiner; William Middlesworth
Journal:  J Pediatr Hematol Oncol       Date:  2013-03       Impact factor: 1.289

9.  Association of CYP3A4 genotype with treatment-related leukemia.

Authors:  C A Felix; A H Walker; B J Lange; T M Williams; N J Winick; N K Cheung; B D Lovett; P C Nowell; I A Blair; T R Rebbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.